TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 DKK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
25,791,919
|
24,339,897
|
21,210,834 |
| Financial expenses |
65,402
|
13,594
|
24,994 |
| Earnings before taxes |
4,021,911
|
3,281,050
|
3,804,263 |
| EBITDA |
5,102,919
|
4,329,971
|
4,842,299 |
| Total assets |
36,829,438
|
33,036,947
|
31,479,494 |
| Current assets |
28,002,041
|
24,433,468
|
22,514,652 |
| Current liabilities |
3,554,537
|
3,097,664
|
2,967,038 |
| Equity capital |
31,673,859
|
28,549,563
|
26,912,705 |
| - share capital |
893
|
895
|
892 |
| Employees (average) |
10,501
|
10,587
|
9,734 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
86.0%
|
86.4%
|
85.5% |
| Turnover per employee |
2,456
|
2,299
|
2,179 |
| Profit as a percentage of turnover |
15.6%
|
13.5%
|
17.9% |
| Return on assets (ROA) |
11.1%
|
10.0%
|
12.2% |
| Current ratio |
787.8%
|
788.8%
|
758.8% |
| Return on equity (ROE) |
12.7%
|
11.5%
|
14.1% |
| Change turnover |
2,257,092
|
3,019,833
|
4,018,421 |
| Change turnover % |
10%
|
14%
|
23% |
| Chg. No. of employees |
-86
|
853
|
1,398 |
| Chg. No. of employees % |
-1%
|
9%
|
17% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.